fda semaglutide warning news october 2025 Beyond the Headlines: Letters to GLP-1 Compounders The FDA sent a warning

This represents a major shift in how doctors may approach cardiovascular prevention in people with overweight/obesity and existing heart disease

Along the same lines, there was a statistically significant reduction in GSRS scores for pain, bloating and diarrhea (values presented in Table 2)

To find out if youre a candidate for Tirzepatide or semaglutide in Arlington, we suggest meeting with our team for a consultation

Notably, the study found that once-daily oral semaglutide was associated with lower HbA1c levels and 12-month weight loss across diverse age groups, including adults aged 75 years and older

GABA Receptors and Seizures: GABAergic dysfunction plays a major role in epilepsy